# Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome

> **NCT00372125** · NA · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 46 (actual)

## Conditions studied

- Prader-Willi Syndrome

## Interventions

- **DRUG:** Norditropin SimpleXx

## Key facts

- **NCT ID:** NCT00372125
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2016-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372125, "Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00372125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*